• Clinical Laserthermia Systems: Clinical Laserthermia Systems presents at Redeye Growth Day (Redeye)
    2023-06-01 07:44
  • Circio Holding: Circio presents at Redeye Growth Day (Redeye)
    2023-06-01 07:44
  • Cantargia: Cantargia presents at Redeye Growth Day (Redeye)
    2023-06-01 07:44
  • Bioservo Technologies: Bioservo Technologies presents at Redeye Growth Day (Redeye)
    2023-06-01 07:44
  • Xspray Pharma: Xspray Pharma presents at Redeye Growth Day (Redeye)
    2023-06-01 07:44
  • Annexin Pharmaceuticals: Annexin Pharmaceuticals presents at Redeye Growth Day (Redeye)
    2023-06-01 07:44
  • AlzeCure Pharma: AlzeCure Pharma presents at Redeye Growth Day (Redeye)
    2023-06-01 07:44
  • Alelion Energy Systems: Alelion Energy Systems presents at Redeye Growth Day (Redeye)
    2023-06-01 07:44
  • Active Biotech: Active Biotech presents at Redeye Growth Day (Redeye)
    2023-06-01 07:44
  • Acconeer: Acconeer presents at Redeye Growth Day (Redeye)
    2023-06-01 07:43
  • Spago Nanomedical: Spago Nanomedical presents at Redeye Growth Day (Redeye)
    2023-06-01 07:43
  • Sprint Bioscience: Sprint Bioscience presents at Redeye Growth Day (Redeye)
    2023-06-01 07:43
  • Strax: Strax presents at Redeye Growth Day (Redeye)
    2023-06-01 07:43
  • TagMaster: TagMaster presents at Redeye Growth Day (Redeye)
    2023-06-01 07:43
  • Tessin Nordic Holding: Tessin Nordic Holding presents at Redeye Growth Day (Redeye)
    2023-06-01 07:43
  • Tobii Dynavox: Tobii Dynavox presents at Redeye Growth Day (Redeye)
    2023-06-01 07:42
  • Truecaller: Truecaller presents at Redeye Growth Day (Redeye)
    2023-06-01 07:42
  • InDex Pharmaceuticals Holding: InDex Pharmaceuticals: USD50m deal with Viatris (Redeye)
    2023-06-01 07:30
  • Inhalation Sciences Sweden: Inhalation Sciences Q1 2023: Heading towards break-even (Redeye)
    2023-06-01 07:30
  • Ultimovacs: Ultimovacs presents at Redeye Growth Day (Redeye)
    2023-06-01 07:19
  • RLS Global: RLS Global Q1 2023: Delay in Europe but progress in the Middle East (Redeye)
    2023-06-01 07:00
  • FluoGuide: Fluoguide Q1 2023: A watched pot never boils (Redeye)
    2023-06-01 06:45
  • Media and Games Invest: Programmatic platform gaining market share (Redeye)
    2023-06-01 06:00
  • Ngenic: Ngenic: SEK10.2m Liquidity boost (Redeye)
    2023-05-31 15:50
  • AcouSort: Analyst Group kommenterar AcouSorts Q1-rapport (Analyst Group)
    2023-05-31 14:40
  • SKAKO: SKAKO (One-pager): Danish industrial machinery developer recovering after Covid-19 (HC Andersen Capital via Inderes)
    2023-05-31 13:56
  • EPTI: Analyst Group Comments on EPTI's Q1 report (Analyst Group)
    2023-05-31 13:55
  • EPTI: Analyst Group kommenterar EPTIs Q1-rapport (Analyst Group)
    2023-05-31 13:55
  • LL Lucky Games: Analyst Group kommenterar LL Lucky Games Q1-rapport (Analyst Group)
    2023-05-31 13:31
  • MapsPeople: MapsPeople: Announces offering of new shares for up to DKK 34.2m with pre-emptive rights for existing shareholders (HC Andersen Capital via Inderes)
    2023-05-31 13:00
  • Fragbite Group: Fragbite Group: Videointervju med vd Marcus Tielman (Redeye)
    2023-05-31 12:00
  • Götenehus Group: ANALYS Götenehus Group: Fortsätter satsningen inom fastighetsutveckling (Analysguiden)
    2023-05-31 11:50
  • CAG Group: Utnyttjar sin finansiella ställning och förvärvar Etendo - CAG Group (Penser Access)
    2023-05-31 11:00
  • Concejo: Fortsätter i rätt riktning - Concejo (Penser Access)
    2023-05-31 11:00
  • Alltainer: Aktieanalys på Alltainer - Står inför spännande tider (Analyst Group)
    2023-05-31 10:47
  • Cantargia: Cantargia: Video interview withe CEO Göran Forsberg (Redeye)
    2023-05-31 10:32
  • Norse Impact: Norse Impact: Q1 23 Initial take (Redeye)
    2023-05-31 10:21
  • Train Alliance: ANALYS Train Alliance: Stark omsättning under första kvartalet (Analysguiden)
    2023-05-31 10:10
  • Prostatype Genomics: Prostatype Q1: The launch is advancing despite limited access to growth capital (Redeye)
    2023-05-31 10:01
  • Prostatype Q1: The launch is advancing despite limited access to growth capital (Redeye)
    2023-05-31 09:29